GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Filgrastim
Related studies linked through entity extraction aliases.
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Tissue Repair in Stem Cell Transplant Recipients
- Status
- TERMINATED
- Phase
- NA
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT
- Status
- TERMINATED
- Phase
- PHASE2
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE3
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2